Nitisinone

Nitisinone
Product Description

Indicated for the treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.

OMGENE LIFE SCIENCES PRIVATE LIMITED

  • IN
  • 2020
    On CPHI since
  • 50 - 99
    Employees
Company types
Pharmaceutical company
Specifications
  • CAS Registry Number
    104206-65-7

OMGENE LIFE SCIENCES PRIVATE LIMITED

  • IN
  • 2020
    On CPHI since
  • 50 - 99
    Employees
Company types
Pharmaceutical company

More Products from OMGENE LIFE SCIENCES PRIVATE LIMITED (44)

  • Linaclotide

    Product Linaclotide

    Indicated in adults for the treatment of irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC)
  • Liraglutide

    Product Liraglutide

    Indicated as an adjunct to diet and exercise to improve glycemic control in patients 10 years and older with type 2   diabetes mellitus,  to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial   infarction, or non-fat...
  • Mebendazole (Micronized)

    Product Mebendazole (Micronized)

    Indicated for the treatment of patients two years of age and older with gastrointestinal infections caused by Ancylostoma duodenale (hookworm), Ascaris lumbricoides (roundworm), Enterobius vermicularis (pinworm), Necator americanus (hookworm), and Trichuris trichiura (whipworm).
  • Midodrine Hydrochloride

    Product Midodrine Hydrochloride

    Indicated for the treatment of symptomatic orthostatic hypotension (OH).
  • Midostaurin

    Product Midostaurin

    Indicated, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy, for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are FLT3 mutation-positive, as detected by a FDA approved test
  • Nintedanib Esylate

    Product Nintedanib Esylate

    Indicated for treatment of Idiopathic Pulmonary Fibrosis,  Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype, Systemic Sclerosis-Associated Interstitial Lung Disease
  • Obeticholic acid

    Product Obeticholic acid

    Indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.
  • Octreotide Acetate

    Product Octreotide Acetate

    Indicated for treatment of Acromegaly, Carcinoid Tumors, VIP-secreting tumors.
  • Oxytocin Acetate

    Product Oxytocin Acetate

    For the temporary relief of symptoms of food cravings, including: constant appetite, increased or insatiable hunger. The peripheral actions of oxytocin mainly reflect secretion from the pituitary gland.
    Purity not les sthan 99% Complete impurity characterization available
  • Pentetreotide

    Product Pentetreotide

    Indium In-111 pentetreotide is an agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors.
  • Plecanatide

    Product Plecanatide

    Indicated in adults for the treatment of: chronic idiopathic constipation (CIC).  irritable bowel syndrome with constipation (IBS-C)
  • Rufinamide

    Product Rufinamide

    Indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults.

OMGENE LIFE SCIENCES PRIVATE LIMITED resources (1)